Markets

Pre-Market Earnings Report for May 16, 2018 : M, CSIQ, OBSV, MGIC, ALT

The following companies are expected to report earnings prior to market open on 05/16/2018. Visit our Earnings Calendar for a full list of expected earnings releases.

Macy's Inc ( M ) is reporting for the quarter ending April 30, 2018. The retail company's consensus earnings per share forecast from the 6 analysts that follow the stock is $0.36. This value represents a 50.00% increase compared to the same quarter last year. M missed the consensus earnings per share in the 2nd calendar quarter of 2017 by -31.43%. Zacks Investment Research reports that the 2019 Price to Earnings ratio for M is 8.14 vs. an industry ratio of 15.10.

Canadian Solar Inc. ( CSIQ ) is reporting for the quarter ending March 31, 2018. The solar company's consensus earnings per share forecast from the 4 analysts that follow the stock is $0.38. This value represents a 480.00% increase compared to the same quarter last year. CSIQ missed the consensus earnings per share in the 1st calendar quarter of 2017 by -900%. Zacks Investment Research reports that the 2018 Price to Earnings ratio for CSIQ is 11.94 vs. an industry ratio of -3.60, implying that they will have a higher earnings growth than their competitors in the same industry.

ObsEva SA ( OBSV ) is reporting for the quarter ending March 31, 2018. The biomedical (gene) company's consensus earnings per share forecast from the 2 analysts that follow the stock is $-0.46. This value represents a 20.69% increase compared to the same quarter last year. Zacks Investment Research reports that the 2018 Price to Earnings ratio for OBSV is -6.61 vs. an industry ratio of -11.20, implying that they will have a higher earnings growth than their competitors in the same industry.

Magic Software Enterprises Ltd. ( MGIC ) is reporting for the quarter ending March 31, 2018. The computer software company's consensus earnings per share forecast from the 2 analysts that follow the stock is $0.13. This value represents a no change for the same quarter last year. The last two quarters MGIC had negative earnings surprises; the latest report they missed by -15.38%. Zacks Investment Research reports that the 2018 Price to Earnings ratio for MGIC is 13.88 vs. an industry ratio of -43.50, implying that they will have a higher earnings growth than their competitors in the same industry.

Altimmune, Inc. ( ALT ) is reporting for the quarter ending March 31, 2018. The drug company's consensus earnings per share forecast from the 1 analyst that follows the stock is $-0.50. This value represents a 66.67% decrease compared to the same quarter last year. ALT missed the consensus earnings per share in the 3rd calendar quarter of 2017 by -47.83%. Zacks Investment Research reports that the 2018 Price to Earnings ratio for ALT is -0.25 vs. an industry ratio of -6.50, implying that they will have a higher earnings growth than their competitors in the same industry.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

OBSV M MGIC ALT CSIQ

Other Topics

Earnings